Guest blog post by Mitigo
Cyber breaches are not acts of God. They are preventable, provided you have taken the right steps to protect your business from attack. The central theme of this article is that the only way to prove to yourself and your senior leadership team that you have put the right defences in place, is to obtain independent assurance.
What is assurance?
Assurance is the process by which you require an independent expert to give a professional opinion on a subject – in this case your cybersecurity measures. Because information that is business critical needs to be reliable.…
Guest blog by Sabrina Griffin, Region Market Development Manager, Life Sciences and Laboratory Products Group at Thermo Fisher Scientific
Imagine a world where scientific education transcends the boundaries of traditional laboratories. Thanks to Thermo Fisher Scientific's groundbreaking initiative, the Immersive Lab, this vision is becoming a reality. In this blog, we'll dive into the immersive and transformative experiences offered by the Immersive Lab that are reshaping the way we learn in the scientific realm.
Embrace a New Learning Experience: Step into a virtual realm where the…
Guest blog by Guy Kaddish, Bidwells Planning Partner
The importance of fostering inclusive growth in Cambridge as the life sciences sector continues to enjoy stratospheric success was debated at a recent Bidwells event joined by Bidwells Planning Partner Guy Kaddish. Here are Guy’s three big key takeaways.
Getting two of Cambridge's leading politicians into the room together to discuss with the real estate sector some of the biggest challenges facing our city was a rare and welcome opportunity. We made the most of it and the discussion was open and constructive and hopefully, everybody…
Guest blog post by RSM
What are the key business risks in healthcare and life sciences?
The need for healthcare and life sciences organisations to enhance their risk management arrangements is more essential than ever. Combined pressures in a post-pandemic environment, including increased cyber-attacks, the legislative and operational complexities following Brexit and changing regulatory frameworks, have seen the role of risk management change in recent years. Risks within the healthcare and life sciences industries are wide ranging and evolving. In this article, we explore the…
Guest blog post by Dr. Panteli Theocharous, Global Vice President, Cell and Gene Therapy Strategic Lead, Thermo Fisher Scientific
Decades of work and new understanding transformed cell and gene therapies (CGTs) from a hyped-up possibility to a life-changing reality for many patients. CGTs represent a growing market in the United States and other regions of the world, with multiple new global approvals expected within the next few years. However, patient challenges and operating model complexities threaten realization of the CGT promise and require innovators and partners to find…
A recent blog post from AMSBIO introduces a selection of the ‘green products’ it offers to life science researchers looking to maintain rigorous scientific standards in their lab whilst also trying to minimize environmental impact.
Laboratories are known to consume a significant amount of energy and produce a considerable amount of waste. However, with the increasing awareness of the importance of sustainability, many life sciences labs are taking steps towards prioritizing sustainable products and practices.
AMSBIO offers a growing range of products including collagenase, exosome standards,…
Guest Blog: Ahead of BioBeat23, Miranda Weston-Smith, BioBeat founder, talks to Alisa Molotova, Investment Manager at Martlet and co-organiser of BioBeat23 about her investment journey.
Miranda: It’s a total pleasure working with you on BioBeat23: Out of adversity comes opportunity on 18 May at the Cambridge Union. I’m curious to know, how did you get into biotech investing?
Alisa: I spent years in the lab studying the intricacies of cellular biology and regenerative medicine. It was a fascinating field, but I soon realised that my passion for science extended beyond the lab…
There is no doubt that AI is a revolution underway, not just in healthcare, but across a broad range of industries. Although, continuing improvements in technology capabilities, such as computing power, and access to data are creating more opportunities for the application of AI in the drug discovery process, Pharma still lags behind other industries for AI adoption. It is interesting to see therefore, the recent UK Government announcement for a 10-year Quantum Strategy, which sees the promise of £2.5bn of Government funding to fuel the use of quantum technologies. When it comes to…
Global life expectancy at birth increased from 66.8 years in 2000 to 73.3 years compared to 2019, and healthy life expectancy at birth increased from 58.3 years to 63.7 years. However, the pandemic has had a detrimental impact on life expectancy and healthy life expectancy and global inequalities remain a challenge. [World Health Statistics 2022, WHO]
Whilst the data confirms that we are living longer, those years are not necessarily spent in good health. The pandemic was a significant cause of an increase in mortality, but as we age the risk of chronic diseases, such as diabetes,…
Guest blog by Naomi Vowles at Sookio
Google Analytics 4 (GA4) is the new generation of Google Analytics. This invaluable tool is a new way of tracking activity on your website.
In July 2023, Google will stop tracking website data on Universal Analytics - so now is the time to get prepared to make the switch!
But where do you begin? Read on to discover the essential steps for getting started with GA4…
1. Find out how Google Analytics 4 (GA4) works
This is an important first step for anyone transitioning to GA4. Google Analytics works by collecting…